Patients Why “rare disease” is a regulatory label, not a patient real... Regulators define a rare disease by how many people have it, and the answer depends on who is counting.
R&D Sponsored Beyond recruitment: Creating patient engagement that lasts In the final episode of our patient- and site-centric solutions interview series, Zoltan Varga discusses the importance of PRE.
R&D Sponsored Turning recruitment potential into enrolment reality In the fourth episode of the IQVIA-sponsored PSCS leadership video series, Karen Townsend, senior director of medical affairs discusses SEELs
R&D How AI simulation could help de-risk obesity and cardiometab... AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.
R&D Sponsored Decentralisation by design: Bringing the trial closer withou... In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.
Patients Moving beyond intent: Building more diverse clinical trials Improving representation is not simply about increasing awareness or setting enrolment targets. It requires identifying and removing the barriers.
News Flagship joins three biotechs together to form Etcelera Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms from its portfolio.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
